SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 155 filers reported holding SAGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | 0.0% | 19 | -44.1% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -40.0% | 34 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $5,000 | -16.7% | 34 | -15.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | 0.0% | 40 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $6,000 | -66.7% | 40 | -62.3% | 0.00% | -62.5% |
| Q4 2017 | $18,000 | +157.1% | 106 | 0.0% | 0.01% | +166.7% |
| Q3 2017 | $7,000 | -22.2% | 106 | -1.9% | 0.00% | -40.0% |
| Q2 2017 | $9,000 | +12.5% | 108 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $8,000 | +33.3% | 108 | -3.6% | 0.00% | +33.3% |
| Q4 2016 | $6,000 | +20.0% | 112 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $5,000 | -16.7% | 112 | -35.6% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | 0.0% | 174 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $6,000 | -25.0% | 174 | +43.8% | 0.01% | -16.7% |
| Q4 2015 | $8,000 | +100.0% | 121 | +37.5% | 0.01% | +100.0% |
| Q3 2015 | $4,000 | -42.9% | 88 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $7,000 | – | 88 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
| GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
| Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
| DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
| Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
| Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
| Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
| Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
| JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |